RxDoctor Payments Data

Zachary Landers

Family · Owosso, MINPI 1811661010

Payments from drug & device makers

$3,802in general payments, 2019–2025

Across 206 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$493
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$480
  • Johnson & Johnson$449
  • Gilead$288
  • Janssen Scientific Affairs, LLC$241
  • plus $611 from 15 others

What the payments were for

  • Food & beverage$3,58794%
  • Education$1995%
  • Gifts$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,802 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$19,690
Medicare patients
179
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab27$737,444
Humira PenAdalimumab26$176,253
Humira(Cf)Adalimumab14$89,551
SimponiGolimumab12$82,158
LinzessLinaclotide95$59,360
CreonLipase/Protease/Amylase29$32,748
Mesalamine47$25,102
Dexlansoprazole DrDexlansoprazole23$6,877
Pantoprazole Sodium333$5,308
Omeprazole215$4,236
Balsalazide Disodium16$3,391
Lansoprazole53$2,868
Colestipol Hcl23$1,566
Budesonide DrBudesonide14$1,479
Sucralfate31$1,311

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara, Simponi$449$819,60239 claims
AbbVieHumira(Cf), Linzess, Creon$1,240$181,659138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.

Other family in Owosso

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →